These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
199 related items for PubMed ID: 15157249
1. HPA-5b (Bra) neonatal alloimmune thrombocytopenia in Quebec: incidence and clinical outcome in 31 cases. Rousseau J, Goldman M, David M. Transfusion; 2004 Jun; 44(6):844-8. PubMed ID: 15157249 [Abstract] [Full Text] [Related]
2. The management of alloimmune neonatal thrombocytopenia. Blanchette VS, Johnson J, Rand M. Baillieres Best Pract Res Clin Haematol; 2000 Sep; 13(3):365-90. PubMed ID: 11030040 [Abstract] [Full Text] [Related]
3. Anti-HPA-9bw (Maxa) fetomaternal alloimmunization, a clinically severe neonatal thrombocytopenia: difficulties in diagnosis and therapy and report on eight families. Kaplan C, Porcelijn L, Vanlieferinghen P, Julien E, Bianchi F, Martageix C, Bertrand G, Jallu V. Transfusion; 2005 Nov; 45(11):1799-803. PubMed ID: 16271107 [Abstract] [Full Text] [Related]
5. Severe neonatal alloimmune thrombocytopenia due to anti-HPA-3a. Boehlen F, Kaplan C, de Moerloose P. Vox Sang; 1998 Jun; 74(3):201-4. PubMed ID: 9595650 [Abstract] [Full Text] [Related]
6. [Intravenous human immunoglobulin treatment for neonatal alloimmune thrombocytopenia due to anti-HPA-5b with severe previous history]. Moncharmont P, Vignal M, Merieux Y, Rigal D. Arch Pediatr; 2007 Sep; 14(9):1094-6. PubMed ID: 17590318 [Abstract] [Full Text] [Related]
7. Neonatal thrombocytopenia: incidence, serological and clinical observations. Uhrynowska M, Maslanka K, Zupanska B. Am J Perinatol; 1997 Aug; 14(7):415-8. PubMed ID: 9263562 [Abstract] [Full Text] [Related]
8. Incidental diagnosis and tempestive therapy in a case of neonatal alloimmune thrombocytopenia due to anti-HPA-5b. Zuppa AA, Cota F, De Luca D, Visintini F, De Turris PL, Tortorolo G. Pediatr Hematol Oncol; 2002 Dec; 19(8):587-91. PubMed ID: 12487835 [Abstract] [Full Text] [Related]
9. Frequencies of maternal platelet alloantibodies and autoantibodies in suspected fetal/neonatal alloimmune thrombocytopenia, with emphasis on human platelet antigen-15 alloimmunization. Mandelbaum M, Koren D, Eichelberger B, Auerbach L, Panzer S. Vox Sang; 2005 Jul; 89(1):39-43. PubMed ID: 15938738 [Abstract] [Full Text] [Related]
10. A prospective study on the prevalence and risk factors for neonatal thrombocytopenia and platelet alloimmunization among 9332 unselected Brazilian newborns. Castro V, Kroll H, Origa AF, Falconi MA, Marques SB, Marba ST, Passini R, Annichino-Bizzacchi JM, Costa FF, Santoso S, Arruda VR. Transfusion; 2007 Jan; 47(1):59-66. PubMed ID: 17207231 [Abstract] [Full Text] [Related]
20. [Significance of maternal alloantibodies for neonatal thrombocytopenia]. Husebekk A, Skogen B. Tidsskr Nor Laegeforen; 2001 Nov 10; 121(27):3160-2. PubMed ID: 11876135 [Abstract] [Full Text] [Related] Page: [Next] [New Search]